tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

TYK Medicines, Inc. Seeks Approval for H Share Full Circulation

Story Highlights
  • TYK Medicines, Inc. applies to convert 4,608,000 unlisted shares into H shares.
  • The conversion aims to list shares on the Hong Kong Stock Exchange, pending regulatory approval.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
TYK Medicines, Inc. Seeks Approval for H Share Full Circulation

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from TYK Medicines, Inc. Class H ( (HK:2410) ).

TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, has submitted an application to the China Securities Regulatory Commission (CSRC) for the conversion of 4,608,000 unlisted shares into H shares. This move aims to list these shares on the Stock Exchange of Hong Kong Limited as part of the H Share Full Circulation initiative. The conversion is contingent upon receiving necessary approvals from relevant regulatory authorities. This development is significant as it could enhance the liquidity of the company’s shares and potentially improve its market positioning.

The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.

More about TYK Medicines, Inc. Class H

Average Trading Volume: 2,113,850

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$8.48B

For detailed information about 2410 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1